← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 1, 2021Last known activity
Jul 10, 2024
Timeline
2010s
- Jun 1, 2016
ProPharma— Founded
- Jun 1, 2018
Xendo BV— Acquired
Drugs by trial phase (5 distinct, 8 trials)
Phase 2 (2 own, 1 via acquisition)
Subsidiaries (1 direct, 2 total across the full acquisition tree)
Recent trials (7)
- NCT06535841CollaboratorPhase 1Jul 10, 2024
- NCT05782179Study directorPhase 1Mar 1, 2023
- NCT05154578Study directorPhase 2Jan 31, 2022
- NCT05093530Study directorPhase 1Oct 13, 2021
- NCT05005247Study directorPhase 1Aug 17, 2021
- NCT04604548CollaboratorPhase 2Aug 9, 2021
- NCT04846036CollaboratorPhase 2Feb 1, 2021
Details
- Founded
- London, GB Jun 1, 2016
- Last known activity
- Jul 10, 2024
Notes
CRO